Real-life use of fluticasone propionate/salmeterol in patients with chronic obstructive pulmonary disease: a French observational study.
about
Diagnosing COPD: advances in training and practice - a systematic reviewNew combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectivesAppropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawalEfficacy of tiotropium-olodaterol fixed-dose combination in COPDRisk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids.Real-life GOLD 2011 implementation: the management of COPD lacks correct classification and adequate treatment.Metabolic Effects Associated with ICS in Patients with COPD and Comorbid Type 2 Diabetes: A Historical Matched Cohort Study.The lung function profile of once-daily tiotropium and olodaterol via Respimat(®) is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler(®) (ENERGITO(®) study).Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: in UK primary care: a real-world, retrospective, observational.Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids?Efficacy of Indacaterol/Glycopyrronium in Patients with COPD Who Have Increased Dyspnea with Daily Activities.The place of inhaled corticosteroids in the treatment of chronic obstructive pulmonary disease: a narrative review.Inhaled treatment of COPD: a Delphi consensus statement.A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease.Patterns of use of long-acting bronchodilators in patients with COPD: A nationwide follow-up study of new users in New Zealand.
P2860
Q26751313-6EC223C9-7BBF-4455-BE1B-710137F074A2Q27024384-0997DCC3-5252-4344-A455-89ABEA74419AQ28074169-AE8634EB-B54D-4455-BBEC-392228B84B20Q28075367-B0C0E2D8-071D-4792-A282-A7886B3D6D6CQ33803143-FD6A04DD-8478-45B6-BFEB-0EAD06479114Q34472717-C6203505-8DBF-4414-A878-EF33B9923BC8Q36141290-FB84158B-D189-4ED9-887D-7B1FAD2D2BB6Q36557670-4E6B14AE-E6A0-404E-8866-F96D5544EE2DQ37732345-593DD4FC-08B0-4C8D-8A95-93966C378E05Q38571581-3F6B33BE-0312-4D91-A757-D8307EB8ABA6Q38604621-3E847BC5-42E3-4D2C-8ACC-D5F1C66488F4Q38827675-DA6D65EE-50BC-4EC3-A516-251BCF68DF6DQ42227819-95CE9F49-8BF6-4822-8089-682E7B2A798FQ47138049-3EA95268-68F0-4E3B-8F9E-89B9552D3017Q47270609-EA368E5D-CF4F-4BDE-8EF1-FE17AB322257
P2860
Real-life use of fluticasone propionate/salmeterol in patients with chronic obstructive pulmonary disease: a French observational study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Real-life use of fluticasone p ...... a French observational study.
@ast
Real-life use of fluticasone p ...... a French observational study.
@en
type
label
Real-life use of fluticasone p ...... a French observational study.
@ast
Real-life use of fluticasone p ...... a French observational study.
@en
prefLabel
Real-life use of fluticasone p ...... a French observational study.
@ast
Real-life use of fluticasone p ...... a French observational study.
@en
P2093
P2860
P356
P1476
Real-life use of fluticasone p ...... a French observational study.
@en
P2093
Bruno Housset
Céline Pribil
Déborah Poirier
Isabelle Boucot
Nathalie Texier
Philippe Serrier
Stéphane Schück
P2860
P2888
P356
10.1186/1471-2466-14-56
P577
2014-04-02T00:00:00Z
P5875
P6179
1029171142